Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.

ABSTRACT: Studies elucidating detailed characteristics of pneumonitis in association with chemo-immunotherapy are limited. We aimed to investigate the characteristics of images, prognostic factors, and clinical course of combination therapy associated with pneumonitis. A multicenter, retrospective cohort study of patients with non-squamous non-small cell lung cancer who received a combination of platinum, pemetrexed, and pembrolizumab was conducted. Patients with confirmed pneumonitis established by an independent multidisciplinary team were enrolled. For 53 patients with pneumonitis, radiographic features at diagnosis predominantly comprised an organizing pneumonia pattern (62%, 33/53). Twelve (23%) patients experienced a worsening respiratory status during pneumonitis management, which was associa

SUBMITTER: Fujimoto D 

PROVIDER: S-EPMC9988982 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature